logo

The COVID-NMA initiative
A living mapping and living systematic review of Covid-19 trials

COVID-NMA is an international research initiative supported by the WHO and Cochrane.

We provide a living mapping of COVID-19 trials available through interactive data visualizations. We are also conducting living evidence synthesis on preventive interventions, treatments and vaccines for COVID-19 to assist decision makers.

See the description of our model here and our living review protocol here.

LIVING MAPPING OF TRIALS

(i.e., trials registered on the WHO platform)
Updated weekly

2200
Randomized Trials
1229 RCTs recruiting

1848
RCTs on treatments
(1055 recruiting)

237
RCTs on prevention
(107 recruiting)

115
RCTs on vaccines
(67 recruiting)

LIVING SYNTHESIS OF PUBLISHED TRIALS

(include both articles and preprints)
Updated daily

144
RCTs with results
included in our evidence synthesis

126
RCTs on treatments

7
RCTs on prevention

9
RCTs on vaccines

Who is using our data?

At least 9 institutions are using our data

  • World Health Organisation (WHO) - See details
  • UK National Institute for Health and Care Excellence (NICE) - See details
  • South African National Department of Health - See details
  • Australian National COVID-19 Clinical Evidence Taskforce - See details
  • UK National Institute for Health Research (NIHR) Complex Review Support Unit - See details
  • NATO Centre of Excellence for Military Medicine - See details
  • Hôpitaux Universitaires de Genève - See details
  • Caribbean Public Health Agency - See details
  • Austrian Institute for Health Technology Assessment - See details

Weekly update

Weekly update: November 30, 2020 to December 4, 2020

Scientific publications arising from COVID-NMA Initiative

4 articles have been published in scientific journals:

Newsletter

To receive updates on our project and research findings, please subscribe to our digest, we will share with you new RCT results and other interesting news.

This work received some funding from the Agence Nationale de la Recherche (ANR), the World Health Organization (WHO), Cochrane France, Center of Research in Epidemiology and StatisticS (CRESS), Centre d’Epidémiologie Clinique (GHU Cochin, Hôtel Dieu, Assistance Publique Hôpitaux de Paris (APHP) and Université de Paris), Centre national de la recherche scientifique (CNRS) and the Federal Ministry of Health, Germany